Ind-Swift Laboratories Files SEBI Compliance Certificate for Q3 FY26
Ind-Swift Laboratories Limited submitted a SEBI compliance certificate for the quarter ended December 31, 2025. The certificate, received from the Registrar and Share Transfer Agent, confirms dematerialization of securities and adherence to SEBI regulations.
This is a standard compliance filing as required by SEBI regulations and does not involve any new business developments, financial results, or corporate actions that would significantly impact the company.
The announcement is a routine regulatory filing and does not contain any material financial or business updates that would positively or negatively impact the company's outlook.
Ind-Swift Laboratories Limited has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. This certificate pertains to the quarter ended December 31, 2025.
The company received this compliance certificate from Alankit Assignments Ltd., its Registrar and Share Transfer Agent, on January 5, 2026. The certificate confirms that physical share certificates received for dematerialization of securities have been processed. Specifically, it states that the securities were listed on the stock exchanges, and after verification, the certificates were mutilated and cancelled, with the depository's name substituted as the registered owner in the company's records.
This filing is a routine compliance requirement for the company to ensure adherence to SEBI regulations regarding depositories and participants.
What to do with a filing like this
Ind-Swift Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Ind-Swift Laboratories Limited. Read the original for the full detail.